The Recall Desk
LowFDA (Drugs)·D-0485-2016·Announced 2015-12-09

Northwind Pharmaceuticals Recalls Prednisone Tablets Due to Incorrect NDC Labeling

Northwind Pharmaceuticals is recalling 40 bottles of Prednisone 20 mg tablets because the NDC number on the container is incorrect.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a minor labeling error (incorrect NDC number) with no reported injuries or illnesses.

Plain-English summary

Northwind Pharmaceuticals LLC is recalling 40 bottles of Prednisone 20 mg tablets, 10-count, prescription only. The product was manufactured by HIKMA Pharmaceuticals, distributed by West-Ward Pharmaceuticals Corp., and repackaged by Northwind Pharmaceuticals. The specific lot number is NW 46400021 with an expiration date of 03/2018.

The recall was initiated because the National Drug Code (NDC) number printed on the container is incorrect. This is a labeling issue classified as 'Not elsewhere classified.'

The affected product was distributed nationwide. Consumers and healthcare providers should check their inventory for this specific lot and NDC number. If found, the product should be returned to the pharmacy or distributor for credit or replacement.

The recalled product

Product
Prednisone 20 mg, Tablet, 10-count bottle, Rx only, Mfg by: HIKMA Pharmaceuticals PO BOX 182400 Amman 11118 Jordan. Dist By: West-Ward Pharmaceuticals Corp., Eatentown, NJ 07724 USA, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC 51655-320-53
Affected units
40

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # NW 46400021
  • Exp 03/2018

Distribution

Distributed nationwide across the United States.